Life Science Analytics Market

Life Science Analytics Market by Type (Predictive, Descriptive, Prescriptive), Application (Sales & Marketing, Regulatory Compliance, R&D, Pharmacovigilance), Component (Software, Service), Delivery (On Premise, On Demand), End User & Region - Global Forecast to 2027

Report Code: HIT 4869 Feb, 2023, by marketsandmarkets.com

The global life science analytics market in terms of revenue was estimated to be worth $27.1 billion in 2022 and is poised to reach $47.5 billion by 2027, growing at a CAGR of 11.8% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends (life science industry trends), pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Growth in this market is mainly driven by the increasing adoption of analytics for sales and marketing applications, the rising prevalence of chronic diseases, and the growing pressure to curb healthcare spending. However, high implementation costs of analytical solutions and patient data privacy concerns are expected to restrain the growth of this market.

Attractive Opportunities in the Life Science Analytics Market

Life Science Analytics Market

To know about the assumptions considered for the study, Request for Free Sample Report

Life Science Analytics Market Dynamics

Driver: Rising pressure to curb healthcare spending

Globally, the cost of healthcare is on the rise due to the growing demand for healthcare services, increasing prices of medical services, development of expensive prescription drugs and medical technologies, unhealthy lifestyles, rapid growth in the geriatric population, rising prevalence of chronic diseases, and lack of transparency of information on prices and quality. Moreover, operational inefficiencies, hospital readmissions, medical errors, and adverse drug events increase healthcare costs. The need to curb growing healthcare costs is one of the key growth drivers for the global market.

Restraint: High implementation costs of advanced analytical solutions

Despite the known benefits of analytics in the life science industry, the high implementation and subscription/licensing fees for advanced analytics solutions is a major limitation owing to budgetary concerns faced by many pharmaceutical companies and other stakeholders. Only top-tier companies have the capability and funding to utilize big data to provide actionable insights effectively. According to industry experts, the cost of these solutions ranges from USD 10,000 to several million, depending on factors such as application areas, type of analytics solutions, product features, delivery model, and amount of data. High price make these solutions less reasonable for small- and medium-sized pharmaceutical and biotechnology companies and CROs with restricted budgets, thereby restricting their adoption. This trend is particularly obvious in emerging economies, where it is always hard to obtain budgets for IT over medical equipment.

Opportunity: Big data analytics for R&D productivity

The life science industry is experiencing various challenges, such as patent expirations, push for generics, increasing costs, lower margins, increasing stringency of FDA regulations, and lower R&D productivity. However, the impact of many of these challenges can be offset/reduced by using advanced technologies, such as analytics. Analytics solutions can process data from multiple sources, such as millions of documents, protocols, study records, images, and applications, to provide a unified view. A potential benefit of big data analytics is to find potential patients to enroll in clinical trials based on social media profiles, genetic information, and information collected in electronic health records and not just on the evaluation of physicians. Companies can also use smart devices to gather large quantities of real-world data that were not available for R&D teams in the past.

Challenge: Shortage of skilled personnel

Globally, there are only a limited number of organizations with sufficient in-house experts to translate large volumes of data into valuable insights. According to Randstad Sourceright’s 2022 Talent Trends report, 33% of C-suite and human capital leaders in the life sciences & pharmaceuticals sector reported that talent scarcity is one of the major factors for the life science sector. According to the Economic Survey 2021, India’s domestic pharmaceutical market is expected to reach USD 65 Billion by 2024. There is still a shortage of skilled professionals in the pharmaceutical industry. The shortage of skilled professionals to handle life science analytics solutions is a major factor restraining the market growth.

The descriptive analytics segment accounted for the largest share of the life science analytics industry in 2021, by type.

On the basis of type, the life science analytics market is bifurcated into descriptive, predictive, and prescriptive analytics. In 2021,the descriptive analytics segment accounted for the largest market share. The large share of this segment is primarily attributed due to the emergence of COVID-19 to understand the disease prognosis and treatment procedure required for the virus.

The sales and marketing segment is expected to grow at the highest CAGR in the life science analytics industry during the forecast period.

On the basis of application, the life science analytics market is bifurcated into research & development (clinical trials and preclinical trials), sales & marketing, regulatory compliance, supply chain optimization, and pharmacovigilance. During the forecast period,the sales & marketing segment is expected to grow at the highest CAGR.The high growth of this segment is attributed to the growing adoption of analytics for sales & marketing activities and increasing significance of post-marketing surveillance.

The pharmaceutical and biotechnology companies segment accounted for the largest share of the life science analytics industry in 2021, by end user.

On the basis of end user, the life science analytics market is bifurcated into pharmaceutical & biotechnology companies, medical device companies, research centers, and third-party administrators (TPAs). In 2021, the pharmaceutical & biotechnology companies segment hold the largest share of the global market.This can be attributed to the increasing use of analytics and rising growth in pharmaceutical industries worldwide.

North America to dominate the life science analytics industry in 2021

On the basis of region, the life science analytics market is bifurcated into North America, Europe, Asia, and the Rest of the World (RoW). In 2021, North America dominated the global market, followed by Europe. However, Asia Pacific is expected to grow at the highest CAGR during the forecast period owing to the increasing adoption of advanced technologies and the growing focus of major players on expanding their presence in emerging Asia Pacific countries.

Life Science Analytics Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Prominent players in the life science analytics market include Oracle (US), IBM (US), SAS Institute Inc. (US), Accenture (Ireland), IQVIA Inc (US), Cognizant< (US), Wipro (India), Allscripts Healthcare, LLC (US), Optum, Inc. (US), Microsoft (US), MaxisIT (US), ExlService Holdings, Inc. (US), Cerner Corporation (US), Cotiviti, Inc. (US), Inovalon (US), CitiusTech Inc (US), Saama Technologies, LLC. (US), Axtria (US), Clarivate (UK), ThoughtSphere (US), ThoughtSpot Inc. (US), Alteryx, Inc. (US), Sisense Inc. (US), Amazon Web Services, Inc., and Veeva Systems (US).

Scope of the Life Science Analytics Industry

Report Metric

Details

Market Revenue in 2022

$27.1 billion

Projected Revenue by 2027

$47.5 billion

Revenue Rate

Poised to Grow at a CAGR of 11.8%

Market Driver

Rising pressure to curb healthcare spending

Market Opportunity

Big data analytics for R&D productivity

The research report categorizes the life science analytics market to forecast revenue and analyze trends (life science industry trends) in each of the following submarkets:

By Type

  • Descriptive Analytics
  • Predictive Analytics
  • Prescriptive Analytics

By Component

  • Services
  • Software

By Delivery Model

  • On-premise model
  • On-demand model

By Application

  • Research & Development
  • Preclinical Trials
  • Clinical Trials
  • Sales & Marketing
  • Regulatory Compliance
  • Supply Chain Optimization
  • Pharmacovigilance

By End User

  • Pharmaceutical & Biotechnology Companies
  • Medical Device Companies
  • Research Centers
  • Third-party Administrators

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific (RoAPAC)
  • Rest of the World (RoW)

Recent Developments of Life Science Analytics Industry

  • In November 2022, IQVIA (US) collaborated with Clalit (Israel) to launch the first Prime Site in the country. The collaboration will allow focus on the future of innovation, including precision medicine and the delivery of data-driven trials.
  • In June 2022, SAS Institute Inc. (US) entered into an agreement with Gunvatta (US) to expedite clinical trials and FDA reporting through the SAS Life Science Analytics Framework on Azure.
  • In March 2022, Wipro Limited (India) partnered with Pandorum (India). This partnership will provide insights into the potential outcomes of specific formulations, apply advanced algorithms to predict and enhance the efficiency of therapeutics, and improve clinical study design.
  • In January 2021, Oracle (US) collaborated with Cognizant (US) to integrate technologies to reduce study startup time and streamline the management of clinical trials.
  • In May 2019, SAS Institute Inc. (US) opened its SAS Cloud offering in an Amazon Web Services Data Center in Singapore.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 32)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
                    FIGURE 1 LIFE SCIENCE ANALYTICS: MARKET SEGMENTATION
           1.3.2 YEARS CONSIDERED
    1.4 CURRENCY CONSIDERED 
    1.5 STAKEHOLDERS 
    1.6 SUMMARY OF CHANGES 
    1.7 RECESSION IMPACT 
 
2 RESEARCH METHODOLOGY (Page No. - 36)
    2.1 RESEARCH DATA 
    2.2 RESEARCH METHODOLOGY DESIGN 
          FIGURE 2 LIFE SCIENCE ANALYTICS MARKET SIZE: RESEARCH DESIGN
           2.2.1 SECONDARY SOURCES
                    2.2.1.1 Key data from secondary sources
           2.2.2 PRIMARY SOURCES
                    FIGURE 3 PRIMARY SOURCES
                    2.2.2.1 Key data from primary sources
                    2.2.2.2 Key life science industry insights
                                FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS
    2.3 MARKET SIZE ESTIMATION 
          FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
          FIGURE 6 GLOBAL LIFE SCIENCE COMMERCIAL ANALYTICS MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION
          FIGURE 7 BOTTOM-UP APPROACH
          FIGURE 8 GLOBAL MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027)
          FIGURE 9 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS
          FIGURE 10 TOP-DOWN APPROACH
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 11 DATA TRIANGULATION METHODOLOGY
    2.5 MARKET SHARE ESTIMATION 
    2.6 STUDY ASSUMPTIONS 
    2.7 LIMITATIONS 
           2.7.1 METHODOLOGY-RELATED LIMITATIONS
           2.7.2 SCOPE-RELATED LIMITATIONS
    2.8 RISK ASSESSMENT 
          TABLE 1 GLOBAL MARKET: RISK ASSESSMENT
    2.9 GLOBAL MARKET: RECESSION IMPACT 
 
3 EXECUTIVE SUMMARY (Page No. - 50)
    FIGURE 12 LIFE SCIENCE ANALYTICS MARKET SIZE, BY TYPE, 2022 VS. 2027 (USD MILLION)
    FIGURE 13 GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    FIGURE 14 GLOBAL LIFE SCIENCE COMMERCIAL ANALYTICS MARKET, BY COMPONENT,  2022 VS. 2027 (USD MILLION)
    FIGURE 15 GLOBAL LIFE SCIENCE INTELLIGENCE MARKET, BY DELIVERY MODEL,  2022 VS. 2027 (USD MILLION)
    FIGURE 16 GLOBAL LIFE SCIENCE ANALYTICS MARKET SIZE, BY END USER, 2022 VS. 2027 (USD MILLION)
    FIGURE 17 GLOBAL LIFE SCIENCE COMMERCIAL ANALYTICS MARKET: GEOGRAPHICAL SNAPSHOT
 
4 PREMIUM INSIGHTS (Page No. - 54)
    4.1 GLOBAL MARKET OVERVIEW 
          FIGURE 18 RISING TECHNOLOGICAL ADVANCEMENTS AND GROWING ADOPTION OF ANALYTICS SOLUTIONS FOR CLINICAL TRIALS TO DRIVE MARKET
    4.2 GLOBAL LIFE SCIENCE INTELLIGENCE MARKET, BY TYPE 
          FIGURE 19 DESCRIPTIVE ANALYTICS SEGMENT TO DOMINATE MARKET IN 2021
    4.3 GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER & REGION 
          FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2021
    4.4 GLOBAL MARKET: GEOGRAPHIC SNAPSHOT 
          FIGURE 21 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 58)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 22 LIFE SCIENCE ANALYTICS MARKET SIZE: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Rising pressure to curb healthcare spending
                                FIGURE 23 HEALTHCARE SPENDING AS A PERCENTAGE OF GDP, BY COUNTRY (2019)
                    5.2.1.2 Rising need for improved data standardization
                    5.2.1.3 Rising technological advancements in analytical solutions
                    5.2.1.4 Impact of big data on life science
                    5.2.1.5 Growing adoption of analytical solutions in clinical trials
                    5.2.1.6 Increasing adoption of analytics for sales & marketing applications
           5.2.2 RESTRAINTS
                    5.2.2.1 High implementation cost of advanced analytical solutions
                    5.2.2.2 Data privacy concerns
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growing focus on value-based care
                    5.2.3.2 Use of analytics in precision & personalized medicine
                    5.2.3.3 Big data analytics for R&D productivity
           5.2.4 CHALLENGES
                    5.2.4.1 Issues associated with data integration
                    5.2.4.2 Shortage of skilled personnel
    5.3 ECOSYSTEM ANALYSIS 
    5.4 VALUE CHAIN ANALYSIS 
          FIGURE 24 GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET: VALUE CHAIN ANALYSIS
    5.5 PORTER’S FIVE FORCES ANALYSIS 
           5.5.1 THREAT FROM NEW ENTRANTS
           5.5.2 THREAT FROM SUBSTITUTES
           5.5.3 BARGAINING POWER OF SUPPLIERS
           5.5.4 BARGAINING POWER OF BUYERS
           5.5.5 INTENSITY OF COMPETITIVE RIVALRY
    5.6 TECHNOLOGY ANALYSIS 
           5.6.1 MACHINE LEARNING
           5.6.2 ARTIFICIAL INTELLIGENCE
           5.6.3 INTERNET OF THINGS
           5.6.4 BIG DATA
    5.7 LIFE SCIENCE INDUSTRY TRENDS 
           5.7.1 INCREASING PARTNERSHIPS & COLLABORATIONS FOR INNOVATION
           5.7.2 GROWING DEMAND FOR AI IN PHARMACEUTICAL INDUSTRY
    5.8 CASE STUDY ANALYSIS 
           5.8.1 CASE STUDY 1
           5.8.2 CASE STUDY 2
           5.8.3 CASE STUDY 3
    5.9 REGULATORY ANALYSIS 
           5.9.1 NORTH AMERICA
           5.9.2 EUROPE
           5.9.3 ASIA PACIFIC
           5.9.4 MIDDLE EAST & AFRICA
           5.9.5 LATIN AMERICA
    5.10 PRICING ANALYSIS 
           TABLE 2 AVERAGE SELLING PRICE OF LIFE SCIENCE ANALYTICS SOLUTIONS, BY APPLICATION
           5.10.1 AVERAGE SELLING PRICE TREND ANALYSIS
    5.11 KEY CONFERENCES AND EVENTS IN 2022–2023 
           TABLE 3 GLOBAL MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
    5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
                     TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS (%)
           5.12.2 BUYING CRITERIA
                     FIGURE 26 KEY BUYING CRITERIA FOR END USERS
                     TABLE 5 KEY BUYING CRITERIA FOR END USERS
 
6 LIFE SCIENCE ANALYTICS MARKET SHARE, BY TYPE (Page No. - 78)
    6.1 INTRODUCTION 
          TABLE 6 GLOBAL LIFE SCIENCE COMMERCIAL ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
    6.2 DESCRIPTIVE ANALYTICS 
           6.2.1 ABILITY TO BE IMPLEMENTED WITH STANDARD AGGREGATE FUNCTIONS TO DRIVE MARKET
                    TABLE 7 DESCRIPTIVE ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 8 NORTH AMERICA: DESCRIPTIVE ANALYTICS MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 9 EUROPE: DESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 10 ASIA PACIFIC: DESCRIPTIVE ANALYTICS MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
    6.3 PREDICTIVE ANALYTICS 
           6.3.1 SIMULATIONS DEVELOPMENT FOR PREDICTION OF  FUTURE TRENDS TO DRIVE MARKET (life science industry trends)
                    TABLE 11 PREDICTIVE ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 12 NORTH AMERICA: PREDICTIVE ANALYTICS MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 13 EUROPE: PREDICTIVE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 14 ASIA PACIFIC: PREDICTIVE ANALYTICS MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
    6.4 PRESCRIPTIVE ANALYTICS 
           6.4.1 REAL-TIME ANALYSIS FOR IMPROVED DECISION-MAKING TO SUPPORT MARKET GROWTH
                    TABLE 15 PRESCRIPTIVE ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 16 NORTH AMERICA: PRESCRIPTIVE ANALYTICS MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 17 EUROPE: PRESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 18 ASIA PACIFIC: PRESCRIPTIVE ANALYTICS MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
 
7 LIFE SCIENCE ANALYTICS MARKET SHARE, BY APPLICATION (Page No. - 86)
    7.1 INTRODUCTION 
          TABLE 19 GLOBAL LIFE SCIENCE INTELLIGENCE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    7.2 RESEARCH & DEVELOPMENT 
          TABLE 20 GLOBAL LIFE SCIENCE ANALYTICS MARKET ANALYSIS: COMMERCIALLY AVAILABLE R&D SOLUTIONS
          TABLE 21 GLOBAL LIFE SCIENCE ANALYTICS MARKET ANALYSIS FOR RESEARCH & DEVELOPMENT, BY REGION,  2020–2027 (USD MILLION)
          TABLE 22 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET RESEARCH FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 23 EUROPE: MARKET FOR RESEARCH & DEVELOPMENT,  BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 24 ASIA PACIFIC: MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 25 GLOBAL LIFE SCIENCE ANALYTICS MARKET ANALYSIS FOR RESEARCH & DEVELOPMENT, BY TYPE,  2020–2027 (USD MILLION)
           7.2.1 CLINICAL TRIALS
                    7.2.1.1 Rising need to streamline clinical data and reduce time & costs to drive market
                                TABLE 26 GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET: COMMERCIALLY AVAILABLE CLINICAL TRIAL SOLUTIONS
                                TABLE 27 GLOBAL LIFE SCIENCE ANALYTICS MARKET RESEARCH FOR CLINICAL TRIALS, BY REGION,  2020–2027 (USD MILLION)
                                TABLE 28 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET RESEARCH FOR CLINICAL TRIALS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 29 EUROPE: LIFE SCIENCE ANALYTICS MARKET RESEARCH  FOR CLINICAL TRIALS, BY COUNTRY,  2020–2027 (USD MILLION)
                                TABLE 30 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET ANALYSIS FOR CLINICAL TRIALS, BY COUNTRY, 2020–2027 (USD MILLION)
           7.2.2 PRECLINICAL TRIALS
                    7.2.2.1 Ability to assist researchers in process innovation and decision support to drive adoption
                                TABLE 31 GLOBAL MARKET: COMMERCIALLY AVAILABLE PRECLINICAL  TRIAL SOLUTIONS
                                TABLE 32 GLOBAL MARKET FOR PRECLINICAL TRIALS, BY REGION,  2020–2027 (USD MILLION)
                                TABLE 33 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET RESEARCH FOR PRECLINICAL TRIALS,  BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 34 EUROPE: MARKET FOR PRECLINICAL TRIALS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 35 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET ANALYSIS FOR PRECLINICAL TRIALS, BY COUNTRY, 2020–2027 (USD MILLION)
    7.3 SALES & MARKETING 
           7.3.1 RISING ANALYSIS OF DIGITAL MARKETING EFFECTIVENESS TO DRIVE ADOPTION
                    TABLE 36 MARKET: COMMERCIALLY AVAILABLE SALES &  MARKETING SOLUTIONS
                    TABLE 37 GLOBAL LIFE SCIENCE ANALYTICS MARKET SEGMENTS FOR SALES & MARKETING, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 38 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET SEGMENTS FOR SALES & MARKETING,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 39 EUROPE: LIFE SCIENCE ANALYTICS MARKET SEGMENTS FOR SALES & MARKETING, BY COUNTRY, 2020–2027(USD MILLION)
                    TABLE 40 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET DEMAND FOR SALES & MARKETING,  BY COUNTRY, 2020–2027 (USD MILLION)
    7.4 PHARMACOVIGILANCE 
           7.4.1 MONITORING OF DRUG TRIALS AND MEDICATION PROGRAMS TO FUEL MARKET UPTAKE
                    TABLE 41 GLOBAL LIFE SCIENCE INTELLIGENCE MARKET: COMMERCIALLY AVAILABLE PHARMACOVIGILANCE SOLUTIONS
                    TABLE 42 GLOBAL LIFE SCIENCE ANALYTICS MARKET SEGMENTS FOR PHARMACOVIGILANCE, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 43 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET SEGMENTS FOR PHARMACOVIGILANCE, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 44 EUROPE: MARKET FOR PHARMACOVIGILANCE, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 45 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET DEMAND FOR PHARMACOVIGILANCE,  BY COUNTRY, 2020–2027 (USD MILLION)
    7.5 REGULATORY COMPLIANCE 
           7.5.1 STRINGENT REQUIREMENTS FOR COMPLIANCE ADHERENCE TO DRIVE ADOPTION OF SOLUTIONS
                    TABLE 46 GLOBAL LIFE SCIENCE ANALYTICS MARKET SEGMENTATION: COMMERCIALLY AVAILABLE REGULATORY COMPLIANCE SOLUTIONS
                    TABLE 47 GLOBAL LIFE SCIENCE ANALYTICS MARKET SEGMENTATION FOR REGULATORY COMPLIANCE, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 48 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET SEGMENTATION FOR REGULATORY COMPLIANCE, BY COUNTRY, 2020–2027(USD MILLION)
                    TABLE 49 EUROPE: LIFE SCIENCE ANALYTICS MARKET SEGMENTATION FOR REGULATORY COMPLIANCE,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 50 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET DEMAND FOR REGULATORY COMPLIANCE,  BY COUNTRY, 2020–2027 (USD MILLION)
    7.6 SUPPLY CHAIN OPTIMIZATION 
           7.6.1 RISING NEED TO REDUCE LOGISTICS COSTS TO SUPPORT MARKET GROWTH
                    TABLE 51 GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET: COMMERCIALLY AVAILABLE SUPPLY CHAIN OPTIMIZATION SOLUTIONS
                    TABLE 52 GLOBAL LIFE SCIENCE ANALYTICS MARKET SEGMENTATION FOR SUPPLY CHAIN OPTIMIZATION, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 53 NORTH AMERICA: MARKET FOR SUPPLY CHAIN OPTIMIZATION, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 54 EUROPE: MARKET FOR SUPPLY CHAIN OPTIMIZATION,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 55 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET DEMAND FOR SUPPLY CHAIN OPTIMIZATION,  BY COUNTRY, 2020–2027 (USD MILLION)
 
8 LIFE SCIENCE ANALYTICS MARKET SHARE, BY COMPONENT (Page No. - 103)
    8.1 INTRODUCTION 
          TABLE 56 GLOBAL LIFE SCIENCE COMMERCIAL ANALYTICS MARKET, BY COMPONENT, 2020–2027(USD MILLION)
    8.2 SERVICES 
           8.2.1 INCREASING UTILIZATION OF SERVICE PROVIDERS FOR IMPLEMENTATION AND MAINTENANCE OF ANALYTICS TO DRIVE MARKET
                    TABLE 57 LIFE SCIENCE ANALYTICS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 58 NORTH AMERICA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 59 EUROPE: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 60 ASIA PACIFIC: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
    8.3 SOFTWARE 
           8.3.1 RISING NEED TO MANAGE CLINICAL TRIALS DATA BY PHARMA-BIOTECH COMPANIES TO DRIVE ADOPTION
                    TABLE 61 LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 62 NORTH AMERICA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 63 EUROPE: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 64 ASIA PACIFIC: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
 
9 LIFE SCIENCE ANALYTICS MARKET SHARE, BY DELIVERY MODEL (Page No. - 109)
    9.1 INTRODUCTION 
          TABLE 65 GLOBAL LIFE SCIENCE INTELLIGENCE MARKET, BY DELIVERY MODEL, 2020–2027 (USD MILLION)
    9.2 ON-PREMISE DELIVERY MODEL 
           9.2.1 PROVISION OF MULTI-VENDOR ARCHITECTURE AND SECURITY BENEFITS TO DRIVE MARKET
                    TABLE 66 GLOBAL LIFE SCIENCE ANALYTICS MARKET DEMAND FOR ON-PREMISE DELIVERY MODEL, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 67 NORTH AMERICA: LIFE SCIENCE ANALYTICS SOLUTIONS MARKET FOR ON-PREMISE DELIVERY MODEL, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 68 EUROPE: LIFE SCIENCE ANALYTICS SOLUTIONS MARKET FOR ON-PREMISE DELIVERY MODEL, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 69 ASIA PACIFIC: LIFE SCIENCE ANALYTICS SOLUTIONS MARKET FOR ON-PREMISE DELIVERY MODEL, BY COUNTRY, 2020–2027 (USD MILLION)
    9.3 ON-DEMAND DELIVERY MODEL 
           9.3.1 REAL-TIME ANALYSIS AND ELIMINATION OF PURCHASING COSTS FOR SOFTWARE & HARDWARE TO DRIVE ADOPTION
                    TABLE 70 GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET: ON-DEMAND SOLUTIONS OFFERED
                    TABLE 71 LIFE SCIENCE ANALYTICS SOLUTIONS MARKET FOR ON-DEMAND DELIVERY MODEL,  BY REGION, 2020–2027 (USD MILLION)
                    TABLE 72 NORTH AMERICA: LIFE SCIENCE ANALYTICS SOLUTIONS MARKET FOR ON-DEMAND DELIVERY MODEL, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 73 EUROPE: LIFE SCIENCE ANALYTICS SOLUTIONS MARKET FOR ON-DEMAND DELIVERY MODEL, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 74 ASIA PACIFIC: LIFE SCIENCE ANALYTICS SOLUTIONS MARKET FOR ON-DEMAND DELIVERY MODEL, BY COUNTRY, 2020–2027 (USD MILLION)
 
10 LIFE SCIENCE ANALYTICS MARKET SHARE, BY END USER (Page No. - 115)
     10.1 INTRODUCTION 
            TABLE 75 GLOBAL LIFE SCIENCE COMMERCIAL ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 
             10.2.1 RISING NEED FOR INNOVATIVE THERAPIES TO ADOPT ANALYTICS FOR PRODUCT DEVELOPMENT
                        TABLE 76 GLOBAL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2027 (USD MILLION)
                        TABLE 77 NORTH AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
                        TABLE 78 EUROPE: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
                        TABLE 79 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
     10.3 MEDICAL DEVICE COMPANIES 
             10.3.1 ADOPTION OF BIG DATA ANALYTICS FOR COMMERCIALIZATION OF DEVICES TO DRIVE MARKET
                        TABLE 80 GLOBAL MARKET: KEY SOLUTIONS OFFERED BY COMPANIES
                        TABLE 81 GLOBAL MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2020–2027 (USD MILLION)
                        TABLE 82 NORTH AMERICA: MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
                        TABLE 83 EUROPE: MARKET FOR MEDICAL DEVICE COMPANIES,  BY COUNTRY, 2020–2027 (USD MILLION)
                        TABLE 84 ASIA PACIFIC: MARKET FOR MEDICAL DEVICE COMPANIES,  BY COUNTRY, 2020–2027 (USD MILLION)
     10.4 RESEARCH CENTERS 
             10.4.1 ANALYZATION OF LARGE VOLUMES OF DATA DUE TO INCREASING RESEARCH ACTIVITIES TO SUPPORT MARKET GROWTH
                        TABLE 85 GLOBAL LIFE SCIENCE INTELLIGENCE MARKET FOR RESEARCH CENTERS, BY REGION,  2020–2027 (USD MILLION)
                        TABLE 86 NORTH AMERICA: MARKET FOR RESEARCH CENTERS,  BY COUNTRY, 2020–2027 (USD MILLION)
                        TABLE 87 EUROPE: MARKET FOR RESEARCH CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)
                        TABLE 88 ASIA PACIFIC: MARKET FOR RESEARCH CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)
     10.5 THIRD-PARTY ADMINISTRATORS (TPAS) 
             10.5.1 RISING R&D OUTSOURCING BY LIFE SCIENCE COMPANIES TO DRIVE MARKET GROWTH
                        TABLE 89 GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR THIRD-PARTY ADMINISTRATORS, BY REGION, 2020–2027 (USD MILLION)
                        TABLE 90 NORTH AMERICA: MARKET FOR THIRD-PARTY ADMINISTRATORS, BY COUNTRY, 2020–2027 (USD MILLION)
                        TABLE 91 EUROPE: MARKET FOR THIRD-PARTY ADMINISTRATORS,  BY COUNTRY, 2020–2027 (USD MILLION)
                        TABLE 92 ASIA PACIFIC: MARKET FOR THIRD-PARTY ADMINISTRATORS,  BY COUNTRY, 2020–2027 (USD MILLION)
 
11 LIFE SCIENCE ANALYTICS MARKET TRENDS, BY REGION (Page No. - 124)
     11.1 INTRODUCTION 
             TABLE 93 GLOBAL LIFE SCIENCE INTELLIGENCE MARKET, BY REGION, 2020–2027 (USD MILLION)
     11.2 NORTH AMERICA 
             FIGURE 27 NORTH AMERICA: MARKET SNAPSHOT
             11.2.1 NORTH AMERICA: RECESSION IMPACT ANALYSIS
                        TABLE 94 NORTH AMERICA: MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
                        TABLE 95 NORTH AMERICA: MARKET, BY TYPE,  2020–2027 (USD MILLION)
                        TABLE 96 NORTH AMERICA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                        TABLE 97 NORTH AMERICA: MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 98 NORTH AMERICA: MARKET, BY COMPONENT,  2020–2027 (USD MILLION)
                        TABLE 99 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET REPORT, BY DELIVERY MODEL,  2020–2027 (USD MILLION)
                        TABLE 100 NORTH AMERICA: LIFE SCIENCE COMMERCIAL ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.2.2 US
                        11.2.2.1 Established economy and increasing R&D expenditure to drive adoption of analytical solutions
                                      TABLE 101 US: MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 102 US: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 103 US: MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 104 US: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 105 US: LIFE SCIENCE ANALYTICS MARKET REPORT, BY DELIVERY MODEL, 2020–2027 (USD MILLION)
                                      TABLE 106 US: LIFE SCIENCE INTELLIGENCE MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.2.3 CANADA
                        11.2.3.1 Rising need for data standardization in life sciences to fuel uptake
                                      TABLE 107 CANADA: LIFE SCIENCE ANALYTICS MARKET TRENDS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 108 CANADA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                      TABLE 109 CANADA: MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 110 CANADA: MARKET, BY COMPONENT,  2020–2027 (USD MILLION)
                                      TABLE 111 CANADA: MARKET, BY DELIVERY MODEL,  2020–2027 (USD MILLION)
                                      TABLE 112 CANADA: LIFE SCIENCE ANALYTICS MARKET REPORT, BY END USER, 2020–2027 (USD MILLION)
     11.3 EUROPE 
             11.3.1 EUROPE: RECESSION IMPACT ANALYSIS
                        TABLE 113 EUROPE: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                        TABLE 114 EUROPE: MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 115 EUROPE: MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                        TABLE 116 EUROPE: MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 117 EUROPE: MARKET, BY COMPONENT,  2020–2027 (USD MILLION)
                        TABLE 118 EUROPE: LIFE SCIENCE ANALYTICS MARKET REPORT, BY DELIVERY MODEL,  2020–2027 (USD MILLION)
                        TABLE 119 EUROPE: LIFE SCIENCE COMMERCIAL ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.3.2 GERMANY
                        11.3.2.1 Growing R&D investments by pharmaceutical & biotechnology companies to drive market
                                      TABLE 120 GERMANY: MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 121 GERMANY: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                      TABLE 122 GERMANY: MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 123 GERMANY: MARKET, BY COMPONENT,  2020–2027 (USD MILLION)
                                      TABLE 124 GERMANY: LIFE SCIENCE ANALYTICS MARKET REPORT, BY DELIVERY MODEL,  2020–2027 (USD MILLION)
                                      TABLE 125 GERMANY: LIFE SCIENCE INTELLIGENCE MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.3.3 FRANCE
                        11.3.3.1 Growing government support for adoption of AI & big data analytics to drive market
                                      TABLE 126 FRANCE: MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 127 FRANCE: MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                      TABLE 128 FRANCE: MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 129 FRANCE: MARKET, BY COMPONENT,  2020–2027 (USD MILLION)
                                      TABLE 130 FRANCE: MARKET, BY DELIVERY MODEL,  2020–2027(USD MILLION)
                                      TABLE 131 FRANCE: LIFE SCIENCE ANALYTICS MARKET GROWTH, BY END USER, 2020–2027 (USD MILLION)
             11.3.4 UK
                        11.3.4.1 Growing number of clinical trials to drive uptake of life science analytics solutions
                                      TABLE 132 UK: LIFE SCIENCE ANALYTICS MARKET TRENDS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 133 UK: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 134 UK: MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 135 UK: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 136 UK: LIFE SCIENCE ANALYTICS MARKET GROWTH, BY DELIVERY MODEL, 2020–2027 (USD MILLION)
                                      TABLE 137 UK: LIFE SCIENCE COMMERCIAL ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.3.5 ITALY
                        11.3.5.1 Growing number of drug approvals to drive uptake of analytics solutions
                                      TABLE 138 ITALY: MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 139 ITALY: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 140 ITALY: MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 141 ITALY: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 142 ITALY: LIFE SCIENCE ANALYTICS MARKET GROWTH, BY DELIVERY MODEL,  2020–2027(USD MILLION)
                                      TABLE 143 ITALY: LIFE SCIENCE INTELLIGENCE MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.3.6 REST OF EUROPE
                        TABLE 144 REST OF EUROPE: MARKET, BY TYPE,  2020–2027 (USD MILLION)
                        TABLE 145 REST OF EUROPE: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                        TABLE 146 REST OF EUROPE: MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 147 REST OF EUROPE: MARKET, BY COMPONENT,  2020–2027 (USD MILLION)
                        TABLE 148 REST OF EUROPE: MARKET, BY DELIVERY MODEL,  2020–2027 (USD MILLION)
                        TABLE 149 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET GROWTH, BY END USER,  2020–2027 (USD MILLION)
     11.4 ASIA PACIFIC 
             FIGURE 28 ASIA PACIFIC: MARKET SNAPSHOT
             11.4.1 ASIA PACIFIC: RECESSION IMPACT ANALYSIS
                        TABLE 150 ASIA PACIFIC: MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
                        TABLE 151 ASIA PACIFIC: MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 152 ASIA PACIFIC: MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                        TABLE 153 ASIA PACIFIC: MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 154 ASIA PACIFIC: MARKET, BY COMPONENT,  2020–2027 (USD MILLION)
                        TABLE 155 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET GROWTH, BY DELIVERY MODEL,  2020–2027 (USD MILLION)
                        TABLE 156 ASIA PACIFIC: LIFE SCIENCE COMMERCIAL ANALYTICS MARKET, BY END USER,  2020–2027 (USD MILLION)
             11.4.2 JAPAN
                        11.4.2.1 Growing government support for clinical R&D activities to drive adoption
                                      TABLE 157 JAPAN: LIFE SCIENCE ANALYTICS MARKET TRENDS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 158 JAPAN: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 159 JAPAN: MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 160 JAPAN: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 161 JAPAN: MARKET, BY DELIVERY MODEL,  2020–2027 (USD MILLION)
                                      TABLE 162 JAPAN: LIFE SCIENCE ANALYTICS MARKET OVERVIEW, BY END USER, 2020–2027 (USD MILLION)
             11.4.3 CHINA
                        11.4.3.1 Growth in life science industry to support adoption of solutions
                                      TABLE 163 CHINA: MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 164 CHINA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 165 CHINA: MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 166 CHINA: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 167 CHINA: LIFE SCIENCE ANALYTICS MARKET OVERVIEW, BY DELIVERY MODEL,  2020–2027 (USD MILLION)
                                      TABLE 168 CHINA: LIFE SCIENCE INTELLIGENCE MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.4.4 INDIA
                        11.4.4.1 Rising R&D expenditure and growing number of drug development activities to support market growth
                                      TABLE 169 INDIA: MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 170 INDIA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 171 INDIA: MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 172 INDIA: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 173 INDIA: LIFE SCIENCE ANALYTICS MARKET OVERVIEW, BY DELIVERY MODEL,  2020–2027 (USD MILLION)
                                      TABLE 174 INDIA: LIFE SCIENCE COMMERCIAL ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.4.5 REST OF ASIA PACIFIC
                        TABLE 175 REST OF ASIA PACIFIC: MARKET, BY TYPE,  2020–2027 (USD MILLION)
                        TABLE 176 REST OF ASIA PACIFIC: MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                        TABLE 177 REST OF ASIA PACIFIC: MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 178 REST OF ASIA PACIFIC: MARKET, BY COMPONENT,  2020–2027 (USD MILLION)
                        TABLE 179 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET OVERVIEW, BY DELIVERY MODEL,  2020–2027 (USD MILLION)
                        TABLE 180 REST OF ASIA PACIFIC: LIFE SCIENCE INTELLIGENCE MARKET, BY END USER,  2020–2027 (USD MILLION)
     11.5 REST OF THE WORLD 
             11.5.1 REST OF THE WORLD: RECESSION IMPACT ANALYSIS
                        TABLE 181 REST OF THE WORLD: LIFE SCIENCE ANALYTICS MARKET TRENDS, BY TYPE,  2020–2027 (USD MILLION)
                        TABLE 182 REST OF THE WORLD: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                        TABLE 183 REST OF THE WORLD: MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 184 REST OF THE WORLD: MARKET, BY COMPONENT,  2020–2027 (USD MILLION)
                        TABLE 185 REST OF THE WORLD: MARKET, BY DELIVERY MODEL,  2020–2027 (USD MILLION)
                        TABLE 186 REST OF THE WORLD: LIFE SCIENCE ANALYTICS MARKET OVERVIEW, BY END USER,  2020–2027 (USD MILLION)
 
12 COMPETITIVE LANDSCAPE (Page No. - 168)
     12.1 INTRODUCTION 
     12.2 STRATEGIES ADOPTED BY KEY PLAYERS 
             12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS
     12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 
             FIGURE 29 LIFE SCIENCE ANALYTICS MARKET: REVENUE SHARE ANALYSIS OF KEY PLAYERS
     12.4 MARKET RANKING ANALYSIS, 2021 
             FIGURE 30 GLOBAL LIFE SCIENCE COMMERCIAL ANALYTICS MARKET: MARKET RANKING ANALYSIS (2021)
     12.5 COMPETITIVE LEADERSHIP MAPPING 
             12.5.1 STARS
             12.5.2 PERVASIVE PLAYERS
             12.5.3 EMERGING LEADERS
             12.5.4 PARTICIPANTS
                        FIGURE 31 COMPETITIVE LEADERSHIP MAPPING FOR KEY PLAYERS (2021)
     12.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS 
             12.6.1 PROGRESSIVE COMPANIES
             12.6.2 STARTING BLOCKS
             12.6.3 RESPONSIVE COMPANIES
             12.6.4 DYNAMIC COMPANIES
                        FIGURE 32 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS (2021)
     12.7 COMPETITIVE BENCHMARKING 
             TABLE 187 GLOBAL LIFE SCIENCE INTELLIGENCE MARKET: OVERALL COMPANY FOOTPRINT
             TABLE 188 GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET: APPLICATION FOOTPRINT OF COMPANIES
             TABLE 189 GLOBAL LIFE SCIENCE INTELLIGENCE MARKET: COMPONENT FOOTPRINT OF COMPANIES
             TABLE 190 GLOBAL LIFE SCIENCE COMMERCIAL ANALYTICS MARKET: REGIONAL FOOTPRINT OF COMPANIES
     12.8 COMPETITIVE SCENARIO 
             12.8.1 PRODUCT/SERVICE LAUNCHES/ENHANCEMENTS
                        TABLE 191 KEY PRODUCT/SERVICE LAUNCHES/ENHANCEMENTS  (JANUARY 2019-DECEMBER 2022)
             12.8.2 DEALS
                        TABLE 192 DEALS (JANUARY 2019-DECEMBER 2022)
             12.8.3 OTHER DEVELOPMENTS
                        TABLE 193 OTHER DEVELOPMENTS (JANUARY 2019-DECEMBER 2022)
 
13 COMPANY PROFILES (Page No. - 180)
     13.1 KEY PLAYERS 
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             13.1.1 ORACLE
                        TABLE 194 ORACLE: COMPANY OVERVIEW
                        FIGURE 33 ORACLE: COMPANY SNAPSHOT (2022)
             13.1.2 IBM
                        TABLE 195 IBM: COMPANY OVERVIEW
                        FIGURE 34 IBM: COMPANY SNAPSHOT (2021)
             13.1.3 SAS INSTITUTE INC.
                        TABLE 196 SAS INSTITUTE INC.: COMPANY OVERVIEW
                        FIGURE 35 SAS INSTITUTE INC.: COMPANY SNAPSHOT (2021)
             13.1.4 ACCENTURE
                        TABLE 197 ACCENTURE: COMPANY OVERVIEW
                        FIGURE 36 ACCENTURE: COMPANY SNAPSHOT (2021)
             13.1.5 IQVIA INC.
                        TABLE 198 IQVIA INC.: COMPANY OVERVIEW
                        FIGURE 37 IQVIA INC.: COMPANY SNAPSHOT (2021)
             13.1.6 COGNIZANT
                        TABLE 199 COGNIZANT: COMPANY OVERVIEW
                        FIGURE 38 COGNIZANT: COMPANY SNAPSHOT (2021)
             13.1.7 WIPRO
                        TABLE 200 WIPRO: COMPANY OVERVIEW
                        FIGURE 39 WIPRO: COMPANY SNAPSHOT (2022)
             13.1.8 ALLSCRIPTS HEALTHCARE, LLC
                        TABLE 201 ALLSCRIPTS HEALTHCARE, LLC: COMPANY OVERVIEW
                        FIGURE 40 ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT (2021)
             13.1.9 OPTUM, INC.
                        TABLE 202 OPTUM, INC.: COMPANY OVERVIEW
                        FIGURE 41 OPTUM, INC.: COMPANY SNAPSHOT (2021)
             13.1.10 MICROSOFT
                        TABLE 203 MICROSOFT: COMPANY OVERVIEW
                        FIGURE 42 MICROSOFT: COMPANY SNAPSHOT (2021)
             13.1.11 MAXISIT
                        TABLE 204 MAXISIT: COMPANY OVERVIEW
             13.1.12 EXLSERVICE HOLDINGS, INC.
                        TABLE 205 EXLSERVICE HOLDINGS, INC.: COMPANY OVERVIEW
                        FIGURE 43 EXLSERVICE HOLDINGS, INC.: COMPANY SNAPSHOT (2021)
             13.1.13 CERNER CORPORATION
                        TABLE 206 CERNER CORPORATION: COMPANY OVERVIEW
                        FIGURE 44 CERNER CORPORATION: COMPANY SNAPSHOT (2021)
             13.1.14 INOVALON
                        TABLE 207 INOVALON: COMPANY OVERVIEW
             13.1.15 CITIUSTECH INC.
                        TABLE 208 CITIUSTECH INC.: COMPANY OVERVIEW
             13.1.16 SAAMA TECHNOLOGIES, LLC
                        TABLE 209 SAAMA TECHNOLOGIES, LLC: COMPANY OVERVIEW
             13.1.17 AXTRIA
                        TABLE 210 AXTRIA: COMPANY OVERVIEW
             13.1.18 CLARIVATE
                        TABLE 211 CLARIVATE: COMPANY OVERVIEW
                        FIGURE 45 CLARIVATE: COMPANY SNAPSHOT (2021)
     13.2 OTHER COMPANIES 
             13.2.1 THOUGHTSPHERE
             13.2.2 THOUGHTSPOT, INC.
             13.2.3 ALTERYX, INC.
             13.2.4 SISENSE INC.
             13.2.5 COTIVITI, INC.
             13.2.6 AMAZON WEB SERVICES, INC.
             13.2.7 VEEVA SYSTEMS
 
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
 
14 APPENDIX (Page No. - 244)
     14.1 DISCUSSION GUIDE 
     14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     14.3 CUSTOMIZATION OPTIONS 
     14.4 RELATED REPORTS 
     14.5 AUTHOR DETAILS 

The study involved four major activities in estimating the current size of the global life science analytics market. Exhaustive secondary research was done to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing values with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was mainly used to identify and collect information for the extensive, technical, market-oriented, and commercial study of the market. Secondary sources include directories; databases such as Bloomberg Business, Factiva, and Wall Street Journal; white papers; and annual reports were also used to obtain key information about major players, market classification, and segmentation according to industry trends (life science industry trends), regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess the prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of primary respondents:

Life Science Analytics Market Size, and Share

Note: Tiers are defined based on a company’s total revenue. As of 2021, Tier 1 = >USD 5 billion, Tier 2 = USD 500 million to USD 5 billion, and Tier 3 = <USD 500 million.

* Others include sales managers, marketing managers, and product managers

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the life science analytics market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research
  • The revenue generated from the sale of life science analytics solutions and services by leading players has been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends (life science industry trends) from both the demand and supply sides.

Report Objectives

  • To define, describe, and forecast the life science analytics market on the basis of type, component, application, delivery model, end-user, and region
  • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets with respect to individual growth trends (life science industry trends), future prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia, and the Rest of the World (RoW)
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as partnerships, agreements, mergers & acquisitions, expansions, product & service launches/upgrades, and R&D activities in the market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs.

The following customization options are available for this report. sss

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
HIT 4869
Published ON
Feb, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Life Science Analytics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback